MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 108 filers reported holding MAXCYTE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,476,635 | -29.3% | 1,434,819 | +4.1% | 0.34% | -22.0% |
| Q2 2023 | $6,327,535 | +7.5% | 1,378,548 | +15.9% | 0.43% | +20.3% |
| Q1 2023 | $5,887,946 | -9.5% | 1,189,484 | -0.2% | 0.36% | -6.8% |
| Q4 2022 | $6,507,255 | -17.0% | 1,191,805 | -1.2% | 0.38% | -20.0% |
| Q3 2022 | $7,839,000 | +40.2% | 1,206,013 | +2.0% | 0.48% | +38.6% |
| Q2 2022 | $5,591,000 | +59.4% | 1,182,016 | +135.6% | 0.35% | +109.0% |
| Q1 2022 | $3,508,000 | +42.6% | 501,811 | +107.9% | 0.17% | +48.2% |
| Q4 2021 | $2,460,000 | +30.0% | 241,377 | +55.8% | 0.11% | +25.8% |
| Q3 2021 | $1,892,000 | – | 154,925 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
| Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
| Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
| Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
| RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
| Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
| Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
| Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
| First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
| Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |